Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors

NCT00996892 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
178
Enrollment
INDUSTRY
Sponsor class

Stopped A recommended Phase 2 dose and schedule was not identified and the study was terminated before initiation of Stage 2B.

Conditions

Interventions

Sponsor

Genentech, Inc.